162 related articles for article (PubMed ID: 20219181)
21. Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT).
Nukada Y; Ashikaga T; Sakaguchi H; Sono S; Mugita N; Hirota M; Miyazawa M; Ito Y; Sasa H; Nishiyama N
Contact Dermatitis; 2011 Dec; 65(6):343-53. PubMed ID: 21767275
[TBL] [Abstract][Full Text] [Related]
22. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
23. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
[TBL] [Abstract][Full Text] [Related]
24. Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants.
De Smedt AC; Van Den Heuvel RL; Van Tendeloo VF; Berneman ZN; Schoeters GE
Toxicol Lett; 2005 Apr; 156(3):377-89. PubMed ID: 15763637
[TBL] [Abstract][Full Text] [Related]
25. An in vitro assay to screen for the sensitizing potential of xenobiotics.
Wanner R; Schreiner M
ALTEX; 2008; 25(2):115-20. PubMed ID: 18551235
[TBL] [Abstract][Full Text] [Related]
26. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers.
Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Kim HR; Lee KJ; Ryu DY
Toxicology; 2008 Sep; 250(2-3):116-23. PubMed ID: 18652873
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration.
Aeby P; Wyss C; Beck H; Griem P; Scheffler H; Goebel C
J Invest Dermatol; 2004 May; 122(5):1154-64. PubMed ID: 15140218
[TBL] [Abstract][Full Text] [Related]
29. Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals.
An S; Kim S; Huh Y; Lee TR; Kim HK; Park KL; Eun HC
Contact Dermatitis; 2009 Apr; 60(4):185-92. PubMed ID: 19338585
[TBL] [Abstract][Full Text] [Related]
30. A potential in vitro epidermal equivalent assay to determine sensitizer potency.
dos Santos GG; Spiekstra SW; Sampat-Sardjoepersad SC; Reinders J; Scheper RJ; Gibbs S
Toxicol In Vitro; 2011 Feb; 25(1):347-57. PubMed ID: 20940038
[TBL] [Abstract][Full Text] [Related]
31. Gene expression studies in cultured dendritic cells: new indicators for the discrimination of skin sensitizers and irritants in vitro.
Szameit S; Vierlinger K; Farmer L; Tuschl H; Noehammer C
Clin Exp Allergy; 2009 Jun; 39(6):856-68. PubMed ID: 19302251
[TBL] [Abstract][Full Text] [Related]
32. The local lymph node assay and skin sensitization testing.
Kimber I; Dearman RJ
Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
[TBL] [Abstract][Full Text] [Related]
33. A new dendritic cell type suitable as sentinel of contact allergens.
Schreiner M; Peiser M; Briechle D; Stahlmann R; Zuberbier T; Wanner R
Toxicology; 2008 Jul; 249(2-3):146-52. PubMed ID: 18547706
[TBL] [Abstract][Full Text] [Related]
34. Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSDC cell line.
Neves BM; Cruz MT; Francisco V; Gonçalo M; Figueiredo A; Duarte CB; Lopes MC
Toxicol Lett; 2008 Feb; 177(1):74-82. PubMed ID: 18281165
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic alterations and cytokine production in THP-1 cells in response to allergens.
Miyazawa M; Ito Y; Yoshida Y; Sakaguchi H; Suzuki H
Toxicol In Vitro; 2007 Apr; 21(3):428-37. PubMed ID: 17118622
[TBL] [Abstract][Full Text] [Related]
36. Selective modulation of B-cell activation markers CD86 and I-Ak on murine draining lymph node cells following allergen or irritant treatment.
Gerberick GF; Cruse LW; Miller CM; Ridder GM
Toxicol Appl Pharmacol; 1999 Sep; 159(2):142-51. PubMed ID: 10495778
[TBL] [Abstract][Full Text] [Related]
37. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
[TBL] [Abstract][Full Text] [Related]
38. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen.
Hulette BC; Ryan CA; Gildea LA; Gerberick GF
Toxicol Appl Pharmacol; 2005 Dec; 209(2):159-66. PubMed ID: 15885735
[TBL] [Abstract][Full Text] [Related]
39. A draining lymph node assay (DLNA) for assessing the sensitizing potential of proteins.
Boverhof DR; Gollapudi BB; Hotchkiss JA; Osterloh-Quiroz M; Woolhiser MR
Toxicol Lett; 2010 Mar; 193(2):144-51. PubMed ID: 20060446
[TBL] [Abstract][Full Text] [Related]
40. Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds.
Vandebriel RJ; Pennings JL; Baken KA; Pronk TE; Boorsma A; Gottschalk R; Van Loveren H
Toxicol Sci; 2010 Sep; 117(1):81-9. PubMed ID: 20566472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
